YANKCOM Partnership’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.68M Sell
19,511
-55
-0.3% -$4.85K 0.58% 36
2026
Q2
$1.53M Buy
19,566
+2,857
+17% +$230K 0.55% 39
2026
Q1
$1.45M Buy
16,709
+913
+6% +$87.5K 0.6% 43
2025
Q4
$1.52M Buy
15,796
+71
+0.5% +$6.9K 0.65% 37
2025
Q3
$1.5M Buy
15,725
+88
+0.6% +$8.09K 0.67% 35
2025
Q2
$1.36M Buy
15,637
+215
+1% +$18.2K 0.67% 36
2025
Q1
$1.39M Buy
15,422
+1,019
+7% +$91.2K 0.76% 34
2024
Q4
$1.15M Buy
+14,403
New +$1.25M 0.62% 42

Other funds holding MDT

YANKCOM Partnership's MDT Position: Q3 2026 in Review

YANKCOM Partnership reduced its Medtronic (MDT) stake by 0.28% in Q3 2026, selling an estimated $4.85K and leaving 19,511 shares worth $1.68M. The position accounts for 0.58% of the portfolio, ranked #36.

YANKCOM Partnership first reported a position in MDT in Q4 2024 and has held it in 8 quarters since. 1,475 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • YANKCOM Partnership held 19,511 shares of Medtronic worth $1.68M as of Q3 2026.
  • YANKCOM Partnership sold 55 Medtronic shares in Q3 2026, an estimated $4.85K.
  • Medtronic made up 0.58% of YANKCOM Partnership's portfolio in Q3 2026, its #36 holding.
  • YANKCOM Partnership first reported a position in Medtronic in Q4 2024 and has held it in 8 quarters since.
  • 1,475 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on YANKCOM Partnership's 13F filing for Q3 2026, filed 15 Oct 2026.